You are here


Presentation by Dr. Capucine Morelot at the TAO Congress on 19/20 November 2015


According to the definition in the 1999 consensus statement of the American Thoracic Society, dyspnoea is “a subjective experience of breathing discomfort that consists of qualitatively distinct sensations that vary in intensity”. Dyspnoea is a frequent and disabling symptom. With regard to cancer patients, it occurs mainly in lung cancer, head and neck cancer as well as breast cancer. Dr. Capucine Morelot explains the pathophysiology and the psychophysiology of dispnoea. She presents the instruments for evaluating dyspnoea in cancer as well as various treatment options. The only recognized therapy are opioids; however, several treatment options which interfere with the neurophysiology are currently being investigated. The treatment of cancer patients with dyspnoea requires a multidisciplinary approach which involves physicians as well as physical and occupational therapists.

Dr. Capucine Morelot, Pitié Salpêtrière, Paris, France

Search this site

Featured videos

Free access to ebooks on cachexia and CINV


Prevention of nausea and vomiting in
adult cancer patients receiving tumour-
directed therapy – 2017 update –

Cancer cachexia: mechanisms and progress in treatment


Stay up-to-date with our monthly e-alert

If you want to regularly receive information on what is happening in Quality of Life in Oncology research sign up to our e-alert.

Subscribe »

QOL (Quality of Life) newsletter e-alert

Quality of Life promotional video

Made possible by an educational grant from Helsinn

Helsinn does not have any influence on the content and all items are subject to independent peer and editorial review

Society Partners

European Cancer Organisation Logo